Atuveciclib (BAY-1143572) is a potent and highly selective, oral PTEFb/CDK9 inhibitor. Atuveciclib (BAY-1143572) inhibits CDK9/CycT1 with an IC50 of 13 nM.
Molecular Weight:
387.43
Purity:
>99%
Target:
CDK
* VAT and and shipping costs not included. Errors and price changes excepted